MG53 mediates a crucial, cholesterol-dependent membrane repair mechanism in cardiomyocytes that protects against ischemia/reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for MG53-targeted cardioprotection; should not yet change clinical management of ischemia/reperfusion injury.
Wang et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: